Elekta AB (publ) (OTCMKTS:EKTAY) Sets New 1-Year Low – Here’s What Happened

Elekta AB (publ) (OTCMKTS:EKTAY)’s stock price hit a new 52-week low during trading on Wednesday . The company traded as low as $5.73 and last traded at $5.74, with a volume of 12359 shares traded. The stock had previously closed at $5.87.

Elekta AB (publ) Price Performance

The firm’s 50 day simple moving average is $6.46 and its two-hundred day simple moving average is $6.63. The firm has a market capitalization of $2.20 billion, a P/E ratio of 18.35 and a beta of 1.23. The company has a debt-to-equity ratio of 0.45, a current ratio of 0.99 and a quick ratio of 0.74.

Elekta AB (publ) (OTCMKTS:EKTAY) last issued its earnings results on Wednesday, August 28th. The company reported $0.04 earnings per share for the quarter. The company had revenue of $359.76 million during the quarter. Elekta AB (publ) had a return on equity of 12.23% and a net margin of 6.25%. As a group, analysts predict that Elekta AB will post 0.41 earnings per share for the current year.

Elekta AB (publ) Company Profile

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.